Effect of vaccination program on immune response, production performance, and carcass composition of Ross 308 broiler chickens

• Published in: Poultry science Vol. 102; no. 10; p. 102918
• Main Authors: Wegner, Marcin, Kokoszyński, Dariusz, Krajewski, Krzysztof, Żurek, Adrian
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01.10.2023; Elsevier
• Subjects: avian metapneumovirus; broiler chicken; immune response; IMMUNOLOGY, HEALTH AND DISEASE; infection bronchitis virus; vaccination program; infection bronchitis virus; vaccination program; avian metapneumovirus; immune response; broiler chicken
• ISSN: 0032-5791; 1525-3171
• DOI: 10.1016/j.psj.2023.102918

The aim of this study was to compare the effect of 2 different vaccination programs using vaccines against infection bronchitis virus (IBV) and avian metapneumovirus (aMPV) on the humoral immune response, production performance, carcass weight and composition, and the percentage of selected internal organs. During the rearing of broiler chickens, blood was collected for serum samples from randomly selected birds from each experimental group on d 1, 21, 28, and 38. Geometric mean titer (GMT) values were determined for the aforementioned diseases using serological ELISA tests, performed during routine veterinary inspections. During rearing, body weight, mortality, and feed consumption were monitored, allowing the calculation of feed consumption per kilogram of body weight gain (FCR) and the European Production Index (EPI). At the end of rearing, 20 chickens were selected for dissection, 10 birds from each group. After slaughter, the weight of the eviscerated carcass was determined, and the percentages of carcass parts and selected internal organs in the body weight were calculated. The vaccination program exerted a significant (P<0.05) effect on body weight on days 14, 21, 28, 35 and 42, the percentage of wings in the carcass and the proportion (%) of heart, liver and spleen in body weight. ELISA showed no significant effect of the vaccination program on the anti-IBV serological response, and no negative effect of covaccination against both diseases on the anti-aMPV serological response.